Drugs Made In America Acquisition Balance Sheet (2024-2025) | DMAA

Balance Sheet Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.00M923.00822.00717.000.01M
Prepaid Assets (Quarter) 0.00M0.07M0.05M0.03M0.01M
Current Assets (Quarter) 0.00M0.07M0.05M0.03M0.01M
Non-Current Assets
Long-Term Investments (Quarter) 232.74M235.16M237.60M239.91M
Other Non-Current Assets (Quarter) 0.55M
Non-Current Assets (Quarter) 0.55M232.74M235.16M237.60M239.91M
Assets (Quarter) 0.55M232.81M235.21M237.63M239.92M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.08M0.00M0.22M
Notes Payables (Quarter) 0.66M0.06M
Payables (Quarter) 0.74M0.06M0.00M0.22M
Accumulated Expenses (Quarter) 0.06M0.15M0.15M0.15M0.15M
Total Current Liabilities (Quarter) 0.80M0.35M0.30M0.46M0.38M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 6.90M6.90M6.90M6.90M
Preferred Stock Liabilities (Quarter) 232.74M235.16M237.60M239.91M
Total Non-Current Liabilities (Quarter) 6.90M
Total Liabilities (Quarter) 0.80M7.25M7.20M7.36M7.28M
Shareholder's Equity
Common Equity (Quarter) -0.24M-7.18M-7.15M-7.33M-7.26M
Shareholder's Equity (Quarter) -0.24M-7.18M-7.15M-7.33M-7.26M
Liabilities and Shareholders Equity (Quarter) 0.55M232.81M235.21M237.63M239.92M
Retained Earnings (Quarter) -0.28M-6.33M-6.46M-6.72M-7.27M
Shares Outstanding (Quarter) 9.86M10.52M10.52M10.52M10.72M